Associate Manager, Preclinical Manufacturing 

Scientist I/II, Integrative Biology (in vitro)

Scientist I/II, Integrative Biology 

Senior Research Associate, Nanoparticle Formulations 

Associate Scientist, Analytical Development - Separation Sciences 

Director, Medicinal Chemistry

Deep Learning AI Lead (Director)

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

A-Alpha Bio

A2 Biotherapeutics

AAVogen

ACELYRIN

AI Proteins

AIRNA Bio

ALX Oncology

AN2 Therapeutics

AOA Dx

ARTBIO

AUM BioTech

AVROBIO

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

Acepodia

Achieve Life Sciences

Acomhal Research

Acrivon Therapeutics

Actym Therapeutics, Inc.

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

Admera Health

Adverum Biotechnologies

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agastiya Biotech

Agena Bioscience

AiViva Biopharma

Ainnocence

AivoCode

Aixa Bio

Akero Therapeutics

Akita Biosciences

Akouos

Alamar Biosciences

Alector

Alida Biosciences

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Oncology

Alphabioregen

Alpine Immune Sciences

AltPep

Alterome Therapeutics

Altis Biosystems

Alto Neuroscience

Alumis

Alveo Technologies

Alveolus Bio

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AnHeart Therapeutics

Anagram Therapeutics

Ancora Biotech LLC

Andes

Andson Biotech

Anebulo Pharmaceuticals

Angiex

Angiocrine Bioscience

Anima Biotech

Ankyra

Annexon Biosciences

Anodyne Nanotech

Anokion

Ansa Biotechnologies

Antheia

Anthos Therapeutics

Apaxon Biotech LLC

Senda Biosciences is pursuing ‘intersystems’ biology to develop medicines. A grand vision in biology is to be able to program any cell in vivo, anywhere in the body, for any function. While many companies are developing methods to program _within the cell_, Senda is also trying to program _to the cell_. Programming to the cell involves understanding the molecule exchange between human and non-human cells that transfer information. Senda is using its ‘Senda Atlas’ platform to deconstruct nature’s code to program “information molecules” and natural nanoparticles with desired bioproperties. Information molecules include mRNA (SendRNA) , DNA, siRNA and gene editors and will enable Senda to target a wide range of currently unreachable cells and tissues in the body.

Senda Biosciences is pursuing ‘intersystems’ biology to develop medicines. A grand vision in biology is to be able to program any cell in vivo, anywhere in the body, for any function. While many companies are developing methods to program within the cell, Senda is also trying to program to the cell. Programming to the cell involves understanding the molecule exchange between human and non-human cells that transfer information. Senda is using its ‘Senda Atlas’ platform to deconstruct nature’s code to program “information molecules” and natural nanoparticles with desired bioproperties. Information molecules include mRNA (SendRNA) , DNA, siRNA and gene editors and will enable Senda to target a wide range of currently unreachable cells and tissues in the body.

Find a biotech startup job.